Channel dredging thrombolytic capsules and making technology

A production process and technology for capsules, which are used in capsule delivery, medical preparations containing active ingredients, plant raw materials, etc., can solve problems such as inability to cure diseases and inconvenience in taking, and achieve a clear mechanism of action, reduce fat content, and stabilize and fragile. Plaque effect

Active Publication Date: 2013-01-16
刘桂沅
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0017] The purpose of the present invention is to overcome the defect that existing Chinese patent medicines used for coronary heart disease, angina pectoris, and myocardial infarction are inconvenient to take and cannot cu

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Channel dredging thrombolytic capsules and making technology
  • Channel dredging thrombolytic capsules and making technology
  • Channel dredging thrombolytic capsules and making technology

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0036] The Tongluo Thrombolytic Capsules are composed of musk, bezoar, ginseng, astragalus, cordyceps, motherwort, angelica, and safflower. The optimal implementation weight of each component is:

[0037] Musk 0.06g

[0038] Bezoar 0.2g

[0039] Ginseng 15g

[0040] Astragalus 15g

[0041] Cordyceps 8g

[0042] Motherwort 15g

[0043] Angelica 15g

[0044] Safflower 10g.

[0045] Said weight unit is not limited to g.

[0046] Described Tongluo Thrombolytic Capsule is made according to the weight of each component described above, and its preparation method is as follows:

[0047] 1) Mix the top-grade raw materials musk and bezoar, pulverize them with a superfine powder purifier, pass through a 300-mesh sieve to form a superfine powder (ie, cell-level fine powder), put it into a glass bottle, and put it in an incubator for later use.

[0048] 2) Ginseng, Radix Astragali, Cordyceps sinensis, Motherwort, Angelica, and Safflower are pulverized with a universal pulverizer, ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Login to view more

Abstract

The invention relates to a Chinese patent medicament for treating heart disease, and in particular relates to channel dredging thrombolytic capsules for radically treating diseases such as coronary heart disease, angina and myocardial infarction and a making technology. The channel dredging thrombolytic capsules are formed by mixing the following components by weight: 0.03 to 0.1 gram of musk, 0.2 to 0.5 part of bezoar, 3 to 19 grams of ginseng, 9 to 30 grams of astragalus root, 5 to 10 grams of cordyceps sinensis, 10 to 30 grams of motherwort, 5 to 15 grams of Chinese angelica, and 3 to 10 grams of safflower. The making technology comprises the following steps of: grinding the musk and the bezoar into super micro powder, preparing coarse powder by extracting active ingredients from the ginseng, the astragalus root, the cordyceps sinensis, the motherwort, the Chinese angelica and the safflower, stirring the super micro powder and the coarse powder uniformly, and filling into capsules, thus obtaining the channel dredging thrombolytic capsules. The channel dredging thrombolytic capsules for treating coronary heart disease, angina and myocardial infarction in clinic have the advantages of extract curative effect, clear acting mechanism, toxic or side effect prevention and adverse response prevention.

Description

technical field [0001] The invention is a Chinese patent medicine for treating heart disease, in particular a collateral-dissolving thrombolytic capsule for radically curing coronary heart disease, angina pectoris, myocardial infarction and other diseases and a production process thereof. Background technique [0002] Coronary heart disease is one of many heart diseases. Coronary heart disease is caused by the deposition of cholesterol in the coronary arteries of the heart, resulting in thickening of the inner wall of the blood vessels, smaller diameter of the blood vessels, obstruction of blood circulation, and insufficient blood supply to the heart muscle itself. When the heart muscle itself is not getting enough blood, the heart doesn't have the strength to beat normally, which causes a myocardial infarction. Angina pectoris is an important symptom of coronary heart disease and an alarm signal of myocardial ischemia, which is most common in elderly patients. Angina pecto...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/533A61K9/48A61P9/10A61K35/55A61K35/413
Inventor 刘桂沅
Owner 刘桂沅
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap